REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 111 filers reported holding REVANCE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $241,000 | -82.7% | 9,567 | -83.2% | 0.00% | -84.2% |
| Q2 2020 | $1,395,000 | +64.5% | 57,089 | -0.3% | 0.02% | +46.2% |
| Q1 2020 | $848,000 | -8.0% | 57,289 | -0.5% | 0.01% | +44.4% |
| Q4 2019 | $922,000 | +15.0% | 57,582 | -6.6% | 0.01% | 0.0% |
| Q3 2019 | $802,000 | +0.1% | 61,654 | -0.1% | 0.01% | 0.0% |
| Q2 2019 | $801,000 | -19.6% | 61,725 | -2.3% | 0.01% | -18.2% |
| Q1 2019 | $996,000 | -21.7% | 63,161 | 0.0% | 0.01% | -31.2% |
| Q4 2018 | $1,272,000 | -19.0% | 63,161 | 0.0% | 0.02% | +6.7% |
| Q3 2018 | $1,570,000 | -9.5% | 63,161 | 0.0% | 0.02% | -11.8% |
| Q2 2018 | $1,734,000 | -10.8% | 63,161 | +0.0% | 0.02% | -15.0% |
| Q1 2018 | $1,945,000 | -20.5% | 63,156 | -7.7% | 0.02% | -13.0% |
| Q4 2017 | $2,447,000 | +23.6% | 68,459 | -4.7% | 0.02% | +43.8% |
| Q3 2017 | $1,980,000 | +26.6% | 71,866 | +21.3% | 0.02% | +23.1% |
| Q2 2017 | $1,564,000 | +323.8% | 59,259 | +448.7% | 0.01% | +225.0% |
| Q4 2015 | $369,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $121,230,000 | 21.92% |
| Rhenman & Partners Asset Management AB | 220,000 | $5,808,000 | 0.83% |
| ArrowMark Colorado Holdings LLC | 2,045,862 | $54,011,000 | 0.67% |
| Vivo Capital, LLC | 77,373 | $2,043,000 | 0.52% |
| Ghost Tree Capital, LLC | 89,295 | $2,357,000 | 0.49% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 124,932 | $3,298,000 | 0.47% |
| Polar Capital LLP | 1,296,371 | $34,220,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 70,095 | $1,851,000 | 0.24% |
| EAM Investors, LLC | 33,897 | $895,000 | 0.15% |
| PointState Capital LP | 438,200 | $11,568,000 | 0.13% |